Biography
Dr. Timothy Vittorio is the Associate Director of the Congestive Heart Failure Program. He is an expert in the field of chronic heart failure and is well published in the area. His primary focus in clinical investigation in heart failure focuses on neurohormono-humoral blockade, endothelial function and exercise physiology. In addition, he also specializes in heart failure prevention and obesity.
Research
- Peripheral vascular actions of beta-adrenoceptor antagonists.
- Differential effects of low verses high-tissue affinity ACE-inhibition.
- Relationship between central (cardiac) and peripheral (endothelism) in chronic heart failure
Publications
Ganda A, Onat D, Demmer RT, Wan E, Vittorio TJ, Sabbah HN, Colombo PC. Venous Congestion and Endothelial Cell Activation in Acute Decompensated Heart Failure. Current Heart Fail Rep 2010 March 17; 7(2): 66-74.
Vittorio TJ, Lanier G, Zolty R, Sarswat N, Tseng C, Colombo PC, Jorde UP. Association between endothelian function and chronotropic incompetence in subjects with chronic heart failure receiving optimal medical therapy. Echocardiography 2010 January 11; 27(3): 294-299.
Maurer MM, Burkhoff D, Maybaum S, Franco V, Vittorio TJ, Williams P, White L, Kamalakkannan G, Myers J, Mancini DM. A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. J Card Fail 2009 June 18; 15(8): 689-699.
Vittorio TJ, Zolty R, Garg PK, Sarswat N, Tseng C, Jorde UP, Colombo PC. Interdependence of cardiac and endothelial function in patients with symptomatic chronic heart failure of nonischemic etiology. Echocardiography 2009 May 26; 26(8): 916-921.
Myers J, Gujja P, Neelagaru S, Hsu L, Vittorio TJ, Jackson-Nelson T, Burkhoff D. End-tidal CO2 pressure and cardiac performance during exercise in heart failure. Med Sci Sports Exerc 2009 December 11; 41(1): 19-25.
Zolty R, Hynes PJ, Vittorio TJ. Severe Left Ventricular Dysfunction May Reverse with Renal Transplantation: Implications for Uremic Cardiomyopathy and Cardiorenal Syndrome. Am J Transplant 2008 September 19; 8(11): 2219-2224.
Zolty R, Bauer C, Allen P, Garrity M, Vittorio TJ. Atrial natriuretic peptide stability. Clin Biochem 2008 May 27; 41(14-15): 1255-1258.
Vittorio TJ, Zolty R, Kasper ME, Khandwalla RM, Hirsh DS, Tseng C, Jorde UP, Ahuja K. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.. J Cardiovasc Pharmacol Ther 2008; 13(1): 51-57.
Jorde UP, Vittorio TJ, Kasper M, Arrezzi E, Colombo PC, Goldsmith R, Ahuja K, Hirsh DS. Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?. Eur J heart Fail 2007 December 21; 10(1): 96-101.
Vittorio TJ, Ahuja K, Kasper M, Turalic H, Tseng C, Jorde UP, Gor C. Comparison of high-versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure. J Renin Angiotensin Aldosterone Syst 2007; 8(4): 200-204.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Vittorio is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Faculty Practice Associates Floor 3
5 East 98th Street
New York, NY 10029
